HEBERT, A.; SCHRIEBER, R.; GLAAB, D.; EICHENFIELD, L. Phase IV Open Label Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of Twice Daily Halobetasol propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, v. 4, n. 6, p. s77, 27 Oct. 2020.